Command Palette

Search for a command to run...

GUJTHEM

412.55-1.88%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Gujarat Themis Biosyn Ltd. struggles in comparison to its peers in profitability and growth metrics. It shows no revenue or profitability growth, making it an underperformer in the sector. In contrast, companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. exhibit strong financial metrics, particularly in profitability and valuation, positioning them as sector leaders.

Key Points
  • Gujarat Themis Biosyn Ltd. shows no revenue or profitability growth, with a PE ratio significantly higher than peers.
  • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. demonstrate strong profitability metrics and attractive valuations.
  • Companies like Sun Pharmaceutical Industries and Torrent Pharmaceuticals have robust growth but trade at higher valuations.
Top Performers
Cipla Ltd.

Strong revenue growth (YoY 13.28%), high ROE (16.63%), and attractive valuation (PE 23.73).

Dr. Reddy's Laboratories Ltd.

Solid profitability with ROE (21.76%) and favorable valuation metrics (PE 15.50).

Mankind Pharma Ltd.

Exceptional revenue growth (YoY 18.12%) and strong ROE (23.15%) despite higher PE (55.18).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.